https www mnl777 co

Sowei 2025-01-11
Column: Belichick hire ignores 'The Carolina Way,' some UNC fans sayhttps www mnl777 co

AfCTA: How Oyo govt is harnessing economic potentialsCHAPEL HILL, N.C. — Bill Belichick spent time after his NFL exit talking with college coaches wanting his thoughts on managing new wrinkles at their level that looked a lot like the pros. The two-minute timeout. The transfer portal as de facto free agency. Collectives generating name, image and likeness (NIL) money for athletes becoming like a payroll. The impending arrival of revenue sharing. It didn't take long for Belichick to envision how a college program should look based on his own NFL experience. "I do think there are a lot of parallels," Belichick said. And that's at least partly why the six-time Super Bowl-winning head coach is now taking over at North Carolina. Years of rapid change at the have only increased the professionalization of college football across the country, with schools adjusting staffing to handle growing duties once seemingly more fitting for a pro team. UNC just happens to be making the most audacious of those bets, bringing in a 72-year-old who has never coached in college and asking him to build what amounts to a mini-NFL front office. But plenty could follow. "I really think there's going to be some of those guys that maybe don't have a job in the NFL anymore," Kansas State general manager Clint Brown said, "and now that this is going to be structured in a way where there is a cap that that's going to be something they're interested in." The rapid changes in college athletics have fueled that, notably with players able to transfer and play right away without sitting out a year and be paid through NIL endorsement opportunities in the past five years. Recruiting is now just as much about bringing in veteran talent through the portal as signing recruits out of high school, mirroring the NFL with free agency and the draft, respectively. And a bigger change looms with revenue sharing, the result of a $2.78 billion legal settlement to antitrust lawsuits. Specifically, that model will allow the biggest schools to establish a pool of about $21.5 million for athletes in the first year, with a final hearing in that case set for April 2025. It will be up to schools to determine how to distribute that money and in which sports, though football's role as the revenue driver in college sports likely means a prominent cut everywhere as a direct parallel to a professional team's salary cap. Throw all that together, and it's why coaches are adjusting their staffs like Florida's Billy Napier interviewing candidates to be the Gators' general manager. "We're built to do it now," Napier said. "The big thing here is that we're getting ready to be in a business model. We have a cap. We have contracts. We have negotiation. We have strategy about how we distribute those funds, and it's a major math puzzle. "We're going to build out a front office here in the next couple of months, and it's primarily to help us manage that huge math problem," Napier added. "There'll be a ton of strategy around that. I'm looking forward to it." Still, that also explains why Nebraska head coach Matt Rhule, the former head coach of the NFL's Carolina Panthers, said: "This job as a head coach is a juggernaut. There's way more to do here than I had to do in the NFL." And it explains why the Tar Heels are betting on Belichick to be the right fit for today's changing climate. "If I was 16 of 17 years old, a coach who came at you and won how many Super Bowls? And he said, 'Come play for me,'" said New York Giants offensive lineman Joshua Ezeudu, now in his third year out of UNC. "I mean, that's pretty hard to turn down now, especially in this day and age, he's telling you to come play for him and he's offering you some money, too. I mean, you can't go wrong with that choice." The timing worked for UNC with Belichick, who was bypassed for some NFL openings after leaving the New England Patriots last year and instead spent months taking a closer look at the college game. Those conversations with coaches — some in the Atlantic Coast, Big Ten and Southeastern conferences, he said Thursday — made him understand how the changes in college aligned with his pro experience. "College kind of came to me this year," Belichick said. "I didn't necessarily go and seek it out." And his mere presence in Chapel Hill makes a difference, with athletic director Bubba Cunningham saying his "visibility" would likely allow the team to raise prices for advertising such as sponsorships and signage. Belichick is also hiring Michael Lombardi, a former NFL general manager and executive, as the Tar Heels' general manager. Cunningham also said the plan is for Belichick to continue his appearances on former NFL quarterbacks Peyton and Eli Manning's "Manningcast" broadcasts during Monday Night Football as well as ESPN's "The Pat McAfee Show" — all giving the coach the chance to promote himself and the program. Yet these steps to reshape football at North Carolina comes with a rising price. Belichick will make $10 million per year in base and supplemental pay, with the first three years of the five-year deal guaranteed, according to a term sheet released by UNC on Thursday. That's roughly double of former coach Mack Brown, whose contract outlined about $4.2 million in base and supplemental salary before bonuses and other add-ons. Additionally, Belichick's deal includes $10 million for a salary pool for assistant coaches and $5.3 million for support staff. That's up from roughly $8.1 million for assistants and $4.8 million for support staff for the 2022 season, according to football financial data for UNC obtained by The Associated Press. And those figures from 2022 under Brown were already up significantly from Larry Fedora's tenure with the 2017 season ($4 million for assistant coaches, $2.3 million for support staff). There is at least one area where the Tar Heels are set for Belichick's arrival: facilities. UNC spent more than $40 million on its football practice complex with an indoor facility (2018) as the biggest project, while other projects include $3 million in upgrades to the locker room and weight room (2019), $14.5 million on renovations to the Kenan Football Center (2022), even $225,000 on Brown's former office (2021). Now it's up to Belichick to rethink the approach to football here for the changing times. "We're taking a risk," Cunningham said. "We're investing more in football with the hope and ambition that the return is going to significantly outweigh the investment." AP Sports Writers Tom Canavan in New Jersey; Mark Long in Florida; and Eric Olson in Nebraska; contributed to this report. Get local news delivered to your inbox!

S&P/TSX composite down nearly 250 points, U.S. stock markets also fallUnlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, had no trouble getting them. The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her health insurance covered all but $25 to $50 of the monthly cost. For , the hardest part of using the new drugs wasn’t access. It was finding out that the much-hyped medications didn’t really work for her. “I have been on Wegovy for a year and a half and have only lost 13 pounds,” said , who watches her diet, drinks plenty of water and exercises regularly. “I’ve done everything right with no success. It’s discouraging.” In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight - up to 50 pounds or more in many cases. But roughly 10% to 15% of patients in those trials were “nonresponders” who lost less than 5% of their body weight. Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of patients - as many as 1 in 5 - may not respond well to the medications. It’s a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect one-size-fits-all results. “It’s all about explaining that different people have different responses,” said Dr. Fatima Cody Stanford, an obesity expert at Massachusetts General Hospital The drugs are known as GLP-1 receptor agonists because they mimic a hormone in the body known as glucagon-like peptide 1. Genetics, hormones and variability in how the brain regulates energy can all influence weight - and a person’s response to the drugs, Stanford said. Medical conditions such as sleep apnea can prevent weight loss, as can certain common medications, such as antidepressants, steroids and contraceptives. “This is a disease that stems from the brain,” said Stanford. “The dysfunction may not be the same” from patient to patient. Despite such cautions, patients are often upset when they start getting the weekly injections but the numbers on the scale barely budge. “It can be devastating,” said Dr. Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. “With such high expectations, there’s so much room for disappointment.” That was the case for , who has battled obesity since childhood and hoped to shed 70 pounds using Wegovy. The drug helped reduce her appetite and lowered her risk of diabetes, but she saw little change in weight. “It’s an emotional roller coaster,” she said. “You want it to work like it does for everybody else.” The medications are typically prescribed along with eating behavior and lifestyle changes. It’s usually clear within weeks whether someone will respond to the drugs, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Weight loss typically begins right away and continues as the dosage increases. For some patients, that just doesn’t happen. For others, side effects such as nausea, vomiting and diarrhea force them to halt the medications, Dushay said. In such situations, patients who were counting on the new drugs to pare pounds may think they’re out of options. “I tell them: It’s not game over,” Dushay said. Trying a different version of the new class of drugs may help. , who didn’t respond well to Wegovy, has started using Zepbound, which targets an additional hormone pathway in the body. After three months of using the drug, she has lost 7 pounds. “I’m hoping it’s slow and steady,” she said. Other people respond well to older drugs, the experts said. Changing diet, exercise, sleep and stress habits can also have profound effects. Figuring out what works typically requires a doctor trained to treat obesity, Saunders noted. “Obesity is such a complex disease that really needs to be treated very comprehensively,” she said. “If what we’re prescribing doesn’t work, we always have a backup plan.” Copyright © 2024 The Washington Times, LLC. Click to Read More and View Comments Click to Hide

Belichick's bid to reshape UNC football latest sign of pro influence on college level

“If you don’t enjoy it at the club, just leave” – Manchester United star brutally urged to quit the club

0 Comments: 0 Reading: 349